Recently, Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. achieved a breakthrough where technology and market success converged — the company has received revenue from an overseas licensing agreement for its core patent on naturalized (bioactive) folate.

This payment from the international market is more than a financial figure; it serves as a global “vote of confidence” in Jinkang Hexin’s capabilities in the field of active folate, affirming the strength of its technology.

As a pioneer and early mover in active folate in China, Jinkang Hexin has been dedicated to this path for eighteen years. That long-term commitment has enabled the company to build a globally leading patent portfolio in active folate, with 42 global invention patents — including 7 PCT international patents — and to establish a complete industrial chain platform covering core raw material R&D, process innovation, and application solutions.

The company holds a U.S. self-affirmed GRAS (Generally Recognized As Safe) status for its calcium salt of 6(S)-5-methyltetrahydrofolic acid, approved for selected conventional food applications (excluding meat and poultry products and infant formulas). The GRAS determination was made based on consensus among an expert panel including former U.S. FDA officials and international specialists, meeting both the “reasonable certainty of no harm” standard under the Federal Food, Drug, and Cosmetic Act and the requirements of Title 21 of the U.S. Code of Federal Regulations.

In 2017, Jinkang Hexin led the effort to establish naturalized (bioactive) folate as a new folic acid fortification source in China — a turning point in industry recognition. From that starting point, the ingredient, marketed as Magnafolate, expanded into therapeutic foods, maternal and children’s milk powders, special dietary products, and even staple wheat flour, offering high-quality folic acid fortification solutions for China and the broader global nutrition and health industry. Core technological advances have taken root across these diverse applications.

Thanks to this deep technical foundation and sustained focus, Jinkang Hexin has become a recognized authority in China’s active folate sector. It is a key contributor to, and driver of, the country’s current official standards and regulatory updates. Its independent innovation continues to provide steady momentum for the national Healthy China initiative.

Commenting on the recent revenue, a company leader said: “This is an important milestone in executing our globalization strategy. Going forward, we will continue leveraging our core patents on naturalized folate to deepen technical collaboration and market synergy with international partners, making our independently developed active folate solutions available to more people around the world, and helping advance the quality of global nutrition and health.”

With solid steps, Jinkang Hexin is sailing the tides of international markets under the banner of science and technology, delivering China-originated active folate innovations to places around the world that need them. Through such efforts, the seeds of better health cross mountains and seas, taking root and growing in the lives of more people.